MarketCapTrends
TMO

Thermo Fisher Scientific Inc.

NYSE · Healthcare
Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007
Revenue
Revenue44.56B42.88B42.86B44.91B39.21B32.22B25.54B24.36B20.92B18.27B16.96B16.89B13.09B12.51B11.56B10.39B9.91B10.50B9.75B
Cost of Revenue
Gross Profit
Operating Expenses
R&D Expenses
SG&A Expense
Total Op. Expenses
Operating Income7.75B7.34B6.86B8.39B10.03B7.79B4.59B3.78B2.96B2.46B2.34B2.50B1.61B1.48B1.25B1.19B1.00B1.23B974.4M
EBITDA
Below the Line
Interest Expense
Pre-Tax Income
Income Tax
Net Income6.70B6.33B6.00B1.27B1.18B1.33B1.04B850.3M980.9M748.4M
Per Share
EPS (basic)
EPS (diluted)
Shares
Basic Shares
Diluted Shares378M383M388M394M397M399M403M406M398M397M402M402M366M367M385M409M423M435M444M